233 related articles for article (PubMed ID: 36727400)
1. Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Largeaud L; Collin M; Monselet N; Vergez F; Fregona V; Larcher L; Hirsch P; Duployez N; Bidet A; Luquet I; Bustamante J; Dufrechou S; Prade N; Nolla M; Hamelle C; Tavitian S; Habib C; Meynier M; Bellanne-Chantelot C; Donadieu J; De Fontbrune FS; Fieschi C; Ferster A; Delhommeau F; Delabesse E; Pasquet M
Haematologica; 2023 Jun; 108(6):1515-1529. PubMed ID: 36727400
[TBL] [Abstract][Full Text] [Related]
2. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome.
West RR; Calvo KR; Embree LJ; Wang W; Tuschong LM; Bauer TR; Tillo D; Lack J; Droll S; Hsu AP; Holland SM; Hickstein DD
Blood Adv; 2022 Feb; 6(3):793-807. PubMed ID: 34529785
[TBL] [Abstract][Full Text] [Related]
3. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV; Arnold DE
Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
[TBL] [Abstract][Full Text] [Related]
4. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of GATA2 deficiency syndrome.
Calvo KR; Hickstein DD
Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
[TBL] [Abstract][Full Text] [Related]
6. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
[TBL] [Abstract][Full Text] [Related]
7. GATA2 deficiency and related myeloid neoplasms.
Wlodarski MW; Collin M; Horwitz MS
Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
[TBL] [Abstract][Full Text] [Related]
8. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
[TBL] [Abstract][Full Text] [Related]
9. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.
Wu Z; Gao S; Diamond C; Kajigaya S; Chen J; Shi R; Palmer C; Hsu AP; Calvo KR; Hickstein DD; Holland SM; Young NS
Blood Adv; 2020 Jun; 4(12):2656-2670. PubMed ID: 32556286
[TBL] [Abstract][Full Text] [Related]
10. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
[TBL] [Abstract][Full Text] [Related]
11. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
12. Myeloid malignancies with somatic
Alfayez M; Wang SA; Bannon SA; Kontoyiannis DP; Kornblau SM; Orange JS; Mace EM; DiNardo CD
Leuk Lymphoma; 2019 Aug; 60(8):2025-2033. PubMed ID: 30648453
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
[No Abstract] [Full Text] [Related]
14. Heterogeneity of GATA2-related myeloid neoplasms.
Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in children with
Fisher KE; Hsu AP; Williams CL; Sayeed H; Merritt BY; Elghetany MT; Holland SM; Bertuch AA; Gramatges MM
Blood Adv; 2017 Feb; 1(7):443-448. PubMed ID: 29296959
[TBL] [Abstract][Full Text] [Related]
16. Germline GATA2 Mutation and Bone Marrow Failure.
McReynolds LJ; Calvo KR; Holland SM
Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
[TBL] [Abstract][Full Text] [Related]
17. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
[TBL] [Abstract][Full Text] [Related]
18. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.
West RR; Hsu AP; Holland SM; Cuellar-Rodriguez J; Hickstein DD
Haematologica; 2014 Feb; 99(2):276-81. PubMed ID: 24077845
[TBL] [Abstract][Full Text] [Related]
19. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency.
Catto LFB; Borges G; Pinto AL; Clé DV; Chahud F; Santana BA; Donaires FS; Calado RT
Blood; 2020 Aug; 136(8):1002-1005. PubMed ID: 32556109
[No Abstract] [Full Text] [Related]
20. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
